Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction (Tutomesh)

March 15, 2012 updated by: David Nocca, Centre Hospitalier Régional Universitaire Montpellier

Multicentric Prospective Randomized Study Comparing Technique of Tension-free Repair With Placement of a Bovine Pericardium Bioprosthesis (Tutopatch® and Tutomesh®) to Current Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction

This is a multicentric prospective randomized study comparing technique of tension-free repair with placement of a bovine pericardium bioprosthesis (Tutopatch® and Tutomesh®) to current conventional surgical techniques in potentially contaminated hernia repair and abdominal wall reconstruction.

The hypothesis is that using Tutomesh® prostheses reduces the risk of postoperative complications at 30 days in the treatment of incisional hernias or complicated abdominal wall hernias (ref early complications) for potentially contaminated fields.

Study Overview

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aix en Provence, France, 13616
        • CH Aix en Provence
      • Amiens, France, 80054
        • CHU Amiens
      • Antibes, France
        • CH Antibes-Juan les Pins
      • Aubagne, France, 13400
        • Clinique de la Casamance
      • Avignon, France, 84900
        • Ch Avignon
      • Beziers, France, 34525
        • CHG Béziers
      • Bondy, France, 93143
        • CHU Jean VERDIER
      • Fréjus, France, 83600
        • CHU Fréjus
      • Grenoble - La tronche, France, 38700
        • CHU Grenoble
      • Marseille, France, 13915
        • Hopital Nord
      • Montpellier, France, 34000
        • CH St Eloi
      • Nantes, France
        • CHU Nantes
      • Nice, France, 06202
        • CHU Archet II
      • Nimes, France
        • CH Nîmes
      • Paris, France, 75004
        • Chu Hotel Dieu
      • Salon de Provence, France, 13658
        • Ch Salon de Provence
      • Strasbourg, France, 67200
        • CH Hautepierre
      • Toulouse, France, 31059
        • CHU Rangueil
      • Tours, France, 37000
        • CHU Trousseau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh:

    • Infected incisional hernia: abdominal wall abscess, chronic fistula
    • Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin)
    • Recurrent incisional hernia with problem of cutaneous healing
    • Incisional hernia requiring important intestinal adhesiolysis
  • Patients signing informed consent form after reading and understanding the information letter _ Patients are more than 18 year old

Exclusion Criteria:

  • Patient with major anesthetic risk (ASA 4)
  • Patient suffering from immunodepression or under immunosuppressor treatment (corticoids…)
  • Patients already enrolled in another study
  • Patient suffering from severe disease not allowing a 1-year follow-up
  • Patient refusing to be enrolled after consulting the information letter
  • Patient presenting with a too large incisional hernia, superior to 140x200 mm
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tutomesh
Technique of abdominal wall reconstruction strengthened by Tutomesh®
Technique of abdominal wall reconstruction or hernia repair strengthened by Tutomesh® in potentially contaminated environment.
Active Comparator: conventional repair
Conventional technique to repair incisional or abdominal wall hernias
Conventional technique to repair potentially contaminated incisional or abdominal wall hernias

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
risk of postoperative complications: occurrence of complications related to pathology or surgery will be evaluated with the report of adverse events and emergency visits
Time Frame: 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
recurrence risk: Assessment of relapse thanks to emergency visits and to adverse events' report
Time Frame: 1 year
1 year
the impact on postoperative pain: Assessment of postoperative pain by postponing analgesics
Time Frame: 1 year
1 year
the socio-economic impact will be evaluated with the concomitant treatment and hospitalisations.
Time Frame: 1 year
1 year
the impact on patients' quality of life: The evaluation of patient's quality of life will be done with the questionnaire quality of life SF12
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Nocca, Dr, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

October 1, 2010

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

February 19, 2010

First Submitted That Met QC Criteria

February 22, 2010

First Posted (Estimate)

February 23, 2010

Study Record Updates

Last Update Posted (Estimate)

March 16, 2012

Last Update Submitted That Met QC Criteria

March 15, 2012

Last Verified

March 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Potentially Contaminated Hernia Repair

Clinical Trials on Technique Tutomesh®

Subscribe